Cutter & Co Brokerage’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,919
Closed -$8.19M 95
2025
Q1
$8.19M Buy
9,919
+1,134
+13% +$944K 1.94% 10
2024
Q4
$6.78M Buy
8,785
+1,925
+28% +$1.59M 1.65% 12
2024
Q3
$6.08M Sell
6,860
-141
-2% -$127K 1.37% 14
2024
Q2
$6.34M Buy
7,001
+577
+9% +$462K 1.54% 13
2024
Q1
$5M Sell
6,424
-362
-5% -$258K 1.23% 18
2023
Q4
$3.96M Sell
6,786
-120
-2% -$70K 1.1% 18
2023
Q3
$3.71M Sell
6,906
-7
-0.1% -$3.61K 1.08% 19
2023
Q2
$3.24M Sell
6,913
-28
-0.4% -$11.7K 0.96% 28
2023
Q1
$2.38M Buy
6,941
+6,110
+735% +$2.06M 0.74% 38
2022
Q4
$304K Sell
831
-20
-2% -$7.09K 0.1% 147
2022
Q3
$275K Buy
851
+51
+6% +$16.2K 0.1% 154
2022
Q2
$259K Sell
800
-597
-43% -$179K 0.09% 172
2022
Q1
$400K Buy
1,397
+557
+66% +$143K 0.12% 138
2021
Q4
$232K Buy
+840
New +$213K 0.06% 230

Other funds holding LLY

Cutter & Co Brokerage's LLY Position: Q2 2025 in Review

Cutter & Co Brokerage sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 9,919 shares — an estimated $8.19M sold.

Cutter & Co Brokerage first reported a position in LLY in Q4 2021 and held it in 14 quarters. The position peaked at $8.19M in Q1 2025. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Cutter & Co Brokerage reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 9,919 Eli Lilly shares in Q2 2025, an estimated $8.19M.
  • Cutter & Co Brokerage first reported a position in Eli Lilly in Q4 2021 and held it in 14 quarters.
  • Cutter & Co Brokerage's Eli Lilly position peaked at $8.19M in Q1 2025.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Cutter & Co Brokerage's 13F filing for Q2 2025.